tradingkey.logo

Omnicell Inc

OMCL
View Detailed Chart

32.260USD

+0.430+1.35%
Close 09/15, 16:00ETQuotes delayed by 15 min
1.50BMarket Cap
64.86P/E TTM

Omnicell Inc

32.260

+0.430+1.35%
Intraday
1m
30m
1h
D
W
M
D

Today

+1.35%

5 Days

-0.22%

1 Month

+1.80%

6 Months

-2.24%

Year to Date

-27.54%

1 Year

-25.25%

View Detailed Chart

TradingKey Stock Score

Currency: USD Updated2025-09-15

Key Insights

The company's fundamentals are relatively very healthy. Its valuation is considered fairly valued,and institutional recognition is very high. Over the past 30 days, multiple analysts have rated the company as a Buy. Despite a weak stock market performance, the company shows strong fundamentals and technicals. The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Industry Ranking
37 / 207
Overall Ranking
139 / 4724
Industry
Healthcare Equipment & Supplies

Support & Resistance

No Data

Score Analysis

Current score
Previous score

Analyst Rating

Based on 8 analysts
Buy
Current Rating
44.000
Target Price
+38.23%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Company Highlights

StrengthsRisks
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 121.87.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD 12.53M.%!(EXTRA int=2)
Overvalued
The company’s latest PE is 64.14, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 49.10M shares, decreasing 15.98% quarter-over-quarter.
Held by The Vanguard
Star Investor The Vanguard holds 5.62M shares of this stock.

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming pharmacy care through outcomes-centric innovation designed to optimize clinical and business outcomes across all settings of care through a portfolio of robotics, smart devices, intelligent software, and services. Its point of care automation solutions is designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company’s XT Series automated dispensing systems for medications and supplies, which are used in nursing units and other clinical areas of the hospital, are designed to support workflows specific to each area of the hospital, with various software and hardware options. For the operating room, the Company also offer specialized automated dispensing systems.
Ticker SymbolOMCL
CompanyOmnicell Inc
CEOMr. Randall A. Lipps
Websitehttps://www.omnicell.com/
KeyAI